Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction

Christina R. Robinson, Justin L. Martin, Lily Zhang, Russell M. Canham, Shuaib M. Abdullah, Joaquin Cigarroa, L. David Hillis, Sabina A. Murphy, Darren K. McGuire, James A. De Lemos, Ellen C. Keeley

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In patients who have ST-segment elevation myocardial infarction (STEMI), a patent infarct-related artery on the initial angiogram is associated with improved clinical outcomes, including decreased mortality. The present study assessed the influence of administering aspirin, β blockers, statins, and angiotensin-converting enzyme inhibitors before STEMI on infarct-related artery patency. Our data demonstrate that patients who have STEMI and receive these medications on an outpatient basis before the event have a higher likelihood of having a patent infarct-related artery compared with patients who do not receive these medications. Further, our data demonstrate a graded association according to the number of such medications being administered: the likelihood of a patent infarct-related artery increased to >50% as the number of these medications increased.

Original languageEnglish (US)
Pages (from-to)7-9
Number of pages3
JournalAmerican Journal of Cardiology
Volume97
Issue number1
DOIs
StatePublished - Jan 1 2006
Externally publishedYes

Fingerprint

Coronary Vessels
Arteries
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Angiotensin-Converting Enzyme Inhibitors
Aspirin
Angiography
Outpatients
Mortality
ST Elevation Myocardial Infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction. / Robinson, Christina R.; Martin, Justin L.; Zhang, Lily; Canham, Russell M.; Abdullah, Shuaib M.; Cigarroa, Joaquin; Hillis, L. David; Murphy, Sabina A.; McGuire, Darren K.; De Lemos, James A.; Keeley, Ellen C.

In: American Journal of Cardiology, Vol. 97, No. 1, 01.01.2006, p. 7-9.

Research output: Contribution to journalArticle

Robinson, CR, Martin, JL, Zhang, L, Canham, RM, Abdullah, SM, Cigarroa, J, Hillis, LD, Murphy, SA, McGuire, DK, De Lemos, JA & Keeley, EC 2006, 'Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction', American Journal of Cardiology, vol. 97, no. 1, pp. 7-9. https://doi.org/10.1016/j.amjcard.2005.07.103
Robinson, Christina R. ; Martin, Justin L. ; Zhang, Lily ; Canham, Russell M. ; Abdullah, Shuaib M. ; Cigarroa, Joaquin ; Hillis, L. David ; Murphy, Sabina A. ; McGuire, Darren K. ; De Lemos, James A. ; Keeley, Ellen C. / Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction. In: American Journal of Cardiology. 2006 ; Vol. 97, No. 1. pp. 7-9.
@article{e91b7de5977443f88a55e805e7988fef,
title = "Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction",
abstract = "In patients who have ST-segment elevation myocardial infarction (STEMI), a patent infarct-related artery on the initial angiogram is associated with improved clinical outcomes, including decreased mortality. The present study assessed the influence of administering aspirin, β blockers, statins, and angiotensin-converting enzyme inhibitors before STEMI on infarct-related artery patency. Our data demonstrate that patients who have STEMI and receive these medications on an outpatient basis before the event have a higher likelihood of having a patent infarct-related artery compared with patients who do not receive these medications. Further, our data demonstrate a graded association according to the number of such medications being administered: the likelihood of a patent infarct-related artery increased to >50{\%} as the number of these medications increased.",
author = "Robinson, {Christina R.} and Martin, {Justin L.} and Lily Zhang and Canham, {Russell M.} and Abdullah, {Shuaib M.} and Joaquin Cigarroa and Hillis, {L. David} and Murphy, {Sabina A.} and McGuire, {Darren K.} and {De Lemos}, {James A.} and Keeley, {Ellen C.}",
year = "2006",
month = "1",
day = "1",
doi = "10.1016/j.amjcard.2005.07.103",
language = "English (US)",
volume = "97",
pages = "7--9",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Infarct-related coronary artery patency and medication use prior to ST-segment elevation myocardial infarction

AU - Robinson, Christina R.

AU - Martin, Justin L.

AU - Zhang, Lily

AU - Canham, Russell M.

AU - Abdullah, Shuaib M.

AU - Cigarroa, Joaquin

AU - Hillis, L. David

AU - Murphy, Sabina A.

AU - McGuire, Darren K.

AU - De Lemos, James A.

AU - Keeley, Ellen C.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - In patients who have ST-segment elevation myocardial infarction (STEMI), a patent infarct-related artery on the initial angiogram is associated with improved clinical outcomes, including decreased mortality. The present study assessed the influence of administering aspirin, β blockers, statins, and angiotensin-converting enzyme inhibitors before STEMI on infarct-related artery patency. Our data demonstrate that patients who have STEMI and receive these medications on an outpatient basis before the event have a higher likelihood of having a patent infarct-related artery compared with patients who do not receive these medications. Further, our data demonstrate a graded association according to the number of such medications being administered: the likelihood of a patent infarct-related artery increased to >50% as the number of these medications increased.

AB - In patients who have ST-segment elevation myocardial infarction (STEMI), a patent infarct-related artery on the initial angiogram is associated with improved clinical outcomes, including decreased mortality. The present study assessed the influence of administering aspirin, β blockers, statins, and angiotensin-converting enzyme inhibitors before STEMI on infarct-related artery patency. Our data demonstrate that patients who have STEMI and receive these medications on an outpatient basis before the event have a higher likelihood of having a patent infarct-related artery compared with patients who do not receive these medications. Further, our data demonstrate a graded association according to the number of such medications being administered: the likelihood of a patent infarct-related artery increased to >50% as the number of these medications increased.

UR - http://www.scopus.com/inward/record.url?scp=29244448972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29244448972&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2005.07.103

DO - 10.1016/j.amjcard.2005.07.103

M3 - Article

C2 - 16377273

AN - SCOPUS:29244448972

VL - 97

SP - 7

EP - 9

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 1

ER -